Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
1,829 articles
New research reveals how portable fans can reduce recovery time from breathing episodes and help patients increase physical activity safely.
Chaska Walton is building programmable immune cells that detect and treat multiple Alzheimer's pathologies simultaneously — a potential paradigm shift.
New actigraphy-based research finds nap duration and frequency predict mortality risk, with morning naps carrying the highest danger signal.
The largest epigenetic testing merger yet aims to connect biological age scores directly to personalized interventions and supplements.
An $80M renewal of the Long Life Family Study uncovers genes, proteins, and fitness traits that predict exceptional longevity.
Heterochronic parabiosis reveals how young blood factors rejuvenate aged retinas via adiponectin receptor signaling.
New findings link poor sleep in epilepsy to dementia risk, identify three Alzheimer's decline patterns, and show how negative environments age the brain faster.
Dasatinib and quercetin, a leading senolytic combo, unexpectedly reduced myelination in healthy mouse brains, mimicking multiple sclerosis damage.
A regenerative knee implant outperformed standard surgical care on pain, mobility, and function across five years — including in osteoarthritis patients.
Genflow Biosciences teams with LNP pioneer Acuitas to advance SIRT6 gene therapy delivery, a fully-funded deal signaling growing confidence in longevity biotech.
Belgian biotech Coultreon raises $125M to advance an oral SIK3 inhibitor that rebalances inflammation rather than suppressing immunity outright.
A landmark review maps the structural, genetic, and molecular changes that erode lung function with age — and why reversing them matters.
